193 related articles for article (PubMed ID: 31484533)
61. Correlation between the changes of serum COX 2, APE1, VEGF, TGF-β and TSGF levels and prognosis in patients with osteosarcoma before and after treatment.
Zhang Q; Dong G; Wang F; Ding W
J Cancer Res Ther; 2020; 16(2):335-342. PubMed ID: 32474521
[TBL] [Abstract][Full Text] [Related]
62. Prognostic significance of relaxin-2 and S100A4 expression in osteosarcoma.
Huang H; Zheng HY; Liu ZL; Zhang L
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2828-34. PubMed ID: 25339476
[TBL] [Abstract][Full Text] [Related]
63. Expression of platelet-derived growth factor-alpha receptor in human osteosarcoma is not a predictor of outcome.
Sulzbacher I; Birner P; Dominkus M; Pichlhofer B; Mazal PR
Pathology; 2010 Dec; 42(7):664-8. PubMed ID: 21080877
[TBL] [Abstract][Full Text] [Related]
64. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
Tian ZZ; Guo XJ; Zhao YM; Fang Y
Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857
[TBL] [Abstract][Full Text] [Related]
65. Protein Expression of Cyclin B1, Transferrin Receptor, and Fibronectin Is Correlated with the Prognosis of Adrenal Cortical Carcinoma.
Moon SJ; Kim JH; Kong SH; Shin CS
Endocrinol Metab (Seoul); 2020 Mar; 35(1):132-141. PubMed ID: 32207273
[TBL] [Abstract][Full Text] [Related]
66. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z
Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921
[TBL] [Abstract][Full Text] [Related]
67. NPRL2 is an independent prognostic factor of osteosarcoma.
Gao Y; Wang J; Fan G
Cancer Biomark; 2012-2013; 12(1):31-6. PubMed ID: 23321467
[TBL] [Abstract][Full Text] [Related]
68. Association of MMP-2 expression and prognosis in osteosarcoma patients.
Zhang M; Zhang X
Int J Clin Exp Pathol; 2015; 8(11):14965-70. PubMed ID: 26823829
[TBL] [Abstract][Full Text] [Related]
69. TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer.
Cheng X; Fan K; Wang L; Ying X; Sanders AJ; Guo T; Xing X; Zhou M; Du H; Hu Y; Ding H; Li Z; Wen X; Jiang W; Yan X; Ji J
Cell Death Dis; 2020 Feb; 11(2):92. PubMed ID: 32024821
[TBL] [Abstract][Full Text] [Related]
70. Expressions of p53, c-MYC, BCL-2 and apoptotic index in human osteosarcoma and their correlations with prognosis of patients.
Wu X; Cai ZD; Lou LM; Zhu YB
Cancer Epidemiol; 2012 Apr; 36(2):212-6. PubMed ID: 21890444
[TBL] [Abstract][Full Text] [Related]
71. [Multivariate analysis for prognostic factors among 43 patients with osteosarcoma].
Zhang B; Pang QJ; Zhang HJ; Yuan Y
Zhongguo Gu Shang; 2011 Dec; 24(12):982-6. PubMed ID: 22276503
[TBL] [Abstract][Full Text] [Related]
72. Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumors.
Sulzbacher I; Birner P; Trieb K; Lang S; Chott A
Virchows Arch; 2002 Oct; 441(4):345-9. PubMed ID: 12404059
[TBL] [Abstract][Full Text] [Related]
73. HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study.
Gorlick S; Barkauskas DA; Krailo M; Piperdi S; Sowers R; Gill J; Geller D; Randall RL; Janeway K; Schwartz C; Grier H; Meyers PA; Gorlick R; Bernstein M; Marina N
Pediatr Blood Cancer; 2014 Sep; 61(9):1558-64. PubMed ID: 24753182
[TBL] [Abstract][Full Text] [Related]
74. High expression of CD105 as a prognostic predictor of early tongue cancer.
Chuang HC; Su CY; Huang HY; Chien CY; Chen CM; Huang CC
Laryngoscope; 2006 Jul; 116(7):1175-9. PubMed ID: 16826056
[TBL] [Abstract][Full Text] [Related]
75. Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma.
Wang YH; Han XD; Qiu Y; Xiong J; Yu Y; Wang B; Zhu ZZ; Qian BP; Chen YX; Wang SF; Shi HF; Sun X
J Surg Oncol; 2012 Mar; 105(3):235-43. PubMed ID: 21866554
[TBL] [Abstract][Full Text] [Related]
76. Prognostic significance of alpha V integrin and VEGF in osteosarcoma after chemotherapy.
Huang Y; Lin Z; Zhuang J; Chen Y; Lin J
Onkologie; 2008 Oct; 31(10):535-40. PubMed ID: 18854653
[TBL] [Abstract][Full Text] [Related]
77. WISP-1 positively regulates angiogenesis by controlling VEGF-A expression in human osteosarcoma.
Tsai HC; Tzeng HE; Huang CY; Huang YL; Tsai CH; Wang SW; Wang PC; Chang AC; Fong YC; Tang CH
Cell Death Dis; 2017 Apr; 8(4):e2750. PubMed ID: 28406476
[TBL] [Abstract][Full Text] [Related]
78. Noninvasive imaging surrogate of angiogenesis in osteosarcoma.
Bajpai J; Gamanagatti S; Sharma MC; Kumar R; Vishnubhatla S; Khan SA; Rastogi S; Malhotra A; Bakhshi S
Pediatr Blood Cancer; 2010 Apr; 54(4):526-31. PubMed ID: 19890899
[TBL] [Abstract][Full Text] [Related]
79. Correlation of IGF1R expression with ABCG2 and CD44 expressions in human osteosarcoma.
Kim CK; Oh S; Kim SJ; Leem SH; Heo J; Chung SH
Genes Genomics; 2018 Apr; 40(4):381-388. PubMed ID: 29892839
[TBL] [Abstract][Full Text] [Related]
80. pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.
Thanapprapasr K; Nartthanarung A; Thanapprapasr D; Jinawath A
PLoS One; 2017; 12(8):e0182989. PubMed ID: 28846700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]